LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

10.18632/oncotarget.25835

Saved in:

Bibliographic Details
Main Authors:	Hee, Y.T, Yan, J, Nizetic, D, Chng, W.-J
Other Authors:	MEDICINE
Format:	Article
Published:	2020
Subjects:	cyclin dependent kinase 4 cyclin dependent kinase 6 Janus kinase 1 Janus kinase 2 ribociclib ruxolitinib STAT protein Article cancer combination chemotherapy cancer inhibition cell cycle progression cell viability controlled study drug efficacy drug potentiation drug targeting enzyme inhibition IC50 lymphoma cell line monotherapy NK T cell lymphoma
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/178073
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-178073
record_format	dspace
spelling	sg-nus-scholar.10635-1780732024-11-09T03:10:13Z LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL) Hee, Y.T Yan, J Nizetic, D Chng, W.-J MEDICINE CANCER SCIENCE INSTITUTE OF SINGAPORE cyclin dependent kinase 4 cyclin dependent kinase 6 Janus kinase 1 Janus kinase 2 ribociclib ruxolitinib STAT protein Article cancer combination chemotherapy cancer inhibition cell cycle progression cell viability controlled study drug efficacy drug potentiation drug targeting enzyme inhibition IC50 lymphoma cell line monotherapy NK T cell lymphoma 10.18632/oncotarget.25835 Oncotarget 9 61 31832-31841 2020-10-20T05:00:52Z 2020-10-20T05:00:52Z 2018 Article Hee, Y.T, Yan, J, Nizetic, D, Chng, W.-J (2018). LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL). Oncotarget 9 (61) : 31832-31841. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.25835 19492553 https://scholarbank.nus.edu.sg/handle/10635/178073 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	cyclin dependent kinase 4 cyclin dependent kinase 6 Janus kinase 1 Janus kinase 2 ribociclib ruxolitinib STAT protein Article cancer combination chemotherapy cancer inhibition cell cycle progression cell viability controlled study drug efficacy drug potentiation drug targeting enzyme inhibition IC50 lymphoma cell line monotherapy NK T cell lymphoma
spellingShingle	cyclin dependent kinase 4 cyclin dependent kinase 6 Janus kinase 1 Janus kinase 2 ribociclib ruxolitinib STAT protein Article cancer combination chemotherapy cancer inhibition cell cycle progression cell viability controlled study drug efficacy drug potentiation drug targeting enzyme inhibition IC50 lymphoma cell line monotherapy NK T cell lymphoma Hee, Y.T Yan, J Nizetic, D Chng, W.-J LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
description	10.18632/oncotarget.25835
author2	MEDICINE
author_facet	MEDICINE Hee, Y.T Yan, J Nizetic, D Chng, W.-J
format	Article
author	Hee, Y.T Yan, J Nizetic, D Chng, W.-J
author_sort	Hee, Y.T
title	LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
title_short	LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
title_full	LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
title_fullStr	LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
title_full_unstemmed	LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)
title_sort	lee011 and ruxolitinib: a synergistic drug combination for natural killer/t-cell lymphoma (nktcl)
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/178073
_version_	1821210129122459648

LEE011 and ruxolitinib: A synergistic drug combination for natural killer/T-cell lymphoma (NKTCL)

Similar Items